Geoffrey Coley
Profile Verified by The Marque
Last Updated: 22 Sep 2026
Board of Trustees, Treasurer
New York, US
Profile Verified by The Marque
Last Updated: 22 Sep 2026
THE MARQUE
In Their Own Right
Biography
Geoffrey Coley is a Senior Executive and distinguished leader in the financial services and investment sectors with over three decades of experience. Geoff has built, managed and fortified all aspects of Global Fixed Income, Equities, Credit Market, Currency & Commodity divisions for several firms. Prior to leaving MUFG, Geoff served as International Business Head and oversaw the development, implementation and operation of front office functions for MUFG's international securities. Prior, Geoff was Co-Head of Global Fixed income at Citigroup after holding several Managing Director roles. He held roles in Fixed Income and Credit Market divisions at Gleacher & Co, Citadel Securities, Chapdelaine Securities, Salomon Brothers and Kidder Peabody. Since 2020, Geoff has been handling private family investments through the COVID-19 pandemic by investing and advising within fixed income and credit markets along with raising early-stage investment for businesses within the tech, biotech and fintech sectors. Geoff's background leading institutional fixed income sales and trading divisions, structuring credit and procuring investments makes him a trusted authority in advising clients, creating portfolios and generating impressive returns. Geoff has served on the Board for the Cancer Research Institute for 25 years and as Treasurer for 10 years. As Treasurer, Geoff oversees all aspects of the financing and investment for CRI, a nonprofit that provides funding for cancer immunotherapy research. The organization, predicated on Dr. William B. Coley's research, seeks to cure cancer by funding innovative clinical and laboratory research, supporting scientists and serving as a trusted source of information on immunotherapy for patients and caregivers. Geoff is the great-grandson of Dr. William B. Coley, known as the "Father of Cancer Immunotherapy" who developed Coley's Toxins, manipulated T-cells and used immunotherapy to save a patient with inoperable cancer in 1930.
The Record
Background
-
1998 — Present
Board of Trustees, Treasurer
Cancer Research Institute
The Cancer Research Institute is the world’s leading nonprofit dedicated exclusively to cancer immunotherapy research and treatment. The Institute works with a global network of researchers, supporters, patients, and advocates to fund leading scientists conducting innovative cancer research and to promote awareness of this research.
-
2015 — 2020
International Business Head
Mitsubishi UFJ Securities Holdings Co. Ltd
Mitsubishi UFJ Securities Holdings is the core securities business of one of the world's leading financial groups, MUFG.
-
2011 — 2013
Managing Director
Gleacher & Co
Gleacher & Company was an independent investment banking firm based in New York City.
-
2011 — 2011
Managing Director, Head of Fixed Income
Citadel Securities LLC
Citadel Securities helps meet the liquidity needs of asset managers, banks, broker-dealers, hedge funds, government agencies, and public pension programs.
-
2009 — 2010
Chief Executive Officer
Chapdelaine & Co
Chapdelaine & Co. is a leading U.S. municipal bond interdealer broker.
-
2004 — 2007
Managing Director, Co-Head of Global Fixed Income, Currencies & Commodities
Citigroup
Citi is a leading global bank which strives to create the best outcomes for their clients and customers with financial solutions that are simple, creative and responsible.
-
2001 — 2003
Managing Director, Co-Head of Global Fixed Income, Credit Markets
Citigroup
Citi is a leading global bank which strives to create the best outcomes for their clients and customers with financial solutions that are simple, creative and responsible.
-
1997 — 2001
Managing Director, Head of US Investment Grade Origination, Syndication & Trading
Citigroup
Citi is a leading global bank which strives to create the best outcomes for their clients and customers with financial solutions that are simple, creative and responsible.
-
1995 — 1997
Managing Director, Head of Investment Grade Secondary Trading
Citigroup
Citi is a leading global bank which strives to create the best outcomes for their clients and customers with financial solutions that are simple, creative and responsible.
-
1994 — 1995
Managing Director, Corporate Bond Trading
Citigroup
Citi is a leading global bank which strives to create the best outcomes for their clients and customers with financial solutions that are simple, creative and responsible.
-
1986 — 1994
Vice President, Corporate Bond Trader
Citigroup
Citi is a leading global bank which strives to create the best outcomes for their clients and customers with financial solutions that are simple, creative and responsible.
-
1982 — 1986
Corporate Bond Trader
Kidder, Peabody & Co.
In The News
Newsfeed
-
4 November 2021 · Newswise
Cancer Research Institute to Honor Developers of COVID-19 mRNA Vaccines in Historic Gathering
Read more
Formative Years
Education
-
University of New Hampshire
Bachelor's Degree, Business Administration
Areas Of Focus